Cyteir Therapeutics, Inc. (CYT)
Mar 18, 2024 - CYT was delisted (reason: company dissolved)
3.020
0.00 (0.00%)
Last trade price

Cyteir Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Cash & Equivalents
147.12189.7210.9429.01
Cash & Cash Equivalents
147.12189.7210.9429.01
Cash Growth
-22.46%1634.53%-62.30%-
Other Current Assets
2.093.351.191.43
Total Current Assets
149.21193.0812.1330.44
Property, Plant & Equipment
1.72.061.290.79
Other Long-Term Assets
2.320.260.320.14
Total Long-Term Assets
4.022.311.60.93
Total Assets
153.23195.3913.7431.37
Accounts Payable
1.131.791.690.6
Other Current Liabilities
4.195.731.451.37
Total Current Liabilities
5.327.513.141.97
Other Long-Term Liabilities
1.630.591.220.32
Total Long-Term Liabilities
1.630.591.220.32
Total Liabilities
6.958.14.362.29
Retained Earnings
-138.11-92.05-49.93-29.1
Shareholders' Equity
146.29187.29-48.03-28.34
Net Cash / Debt
147.12189.7210.9429.01
Net Cash / Debt Growth
-22.46%1634.53%-62.30%-
Net Cash Per Share
4.179.737.146.60
Working Capital
143.89185.578.9928.47
Book Value Per Share
4.159.61-31.37-6.44
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).